GSR, crypto's capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc.

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

After months of behind-the-scenes action, Litecoin, Bitcoin’s little sister, might be ready to make a major splash. Litecoin ...

MEI Pharma announced a $100 million private placement to accumulate Litecoin, as well as the addition of Charlie Lee to its ...

LTC technical analysis shows Litecoin testing resistance at $117. A breakout could lead to 14% gains, with $100 as a key ...

Litecoin price prediction chatter has returned with force after LTC surged 23% in a single day, hitting $119, its highest ...

Shiba Inu (SHIB) has surpassed Litecoin (LTC) in the global cryptocurrency ranking after experiencing a surge in price and a ...

Tracing the weekly technical analysis, Litecoin has broken through the 55-EMA and 200-EMA—two indicators often used by medium ...

For example, if a user invests $12,800 in the Bitcoin Miner S21 XP Hyd hash power contract (with a 40-day term), the ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied ...

Litecoin nears $110 resistance amid bullish signals: whale accumulation, exchange outflows, and a double bottom pattern ...

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...